{{Rsnum
|rsid=2069408
|Gene=CDK2
|Chromosome=12
|position=55970537
|Orientation=plus
|GMAF=0.2378
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CDK2,PMEL
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 50.4 | 37.2 | 12.4
| HCB | 57.8 | 34.1 | 8.1
| JPT | 54.0 | 44.2 | 1.8
| YRI | 91.8 | 8.2 | 0.0
| ASW | 77.2 | 21.1 | 1.8
| CHB | 57.8 | 34.1 | 8.1
| CHD | 61.5 | 33.9 | 4.6
| GIH | 69.3 | 25.7 | 5.0
| LWK | 89.9 | 10.1 | 0.0
| MEX | 59.6 | 33.3 | 7.0
| MKK | 73.7 | 25.0 | 1.3
| TSI | 43.1 | 51.0 | 5.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21804548
|Trait=None
|Title=Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population.
|RiskAllele=C
|Pval=1E-10
|OR=1.1500
|ORtxt=[1.10-1.20]
}}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=18281541
|Title=Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
|OA=1
}}

{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}